Skip to content

Lawsuit Pended Against Publicis Health for Actions in OxyContin Marketing Campaign

Lawsuit filed by Massachusetts Attorney General Maura Healey against Publicis Health, alleging misleading advertising tactics.

Pharmaceutical company Publicis Health under legal scrutiny for alleged involvement in the...
Pharmaceutical company Publicis Health under legal scrutiny for alleged involvement in the marketing of OxyContin

Lawsuit Pended Against Publicis Health for Actions in OxyContin Marketing Campaign

In a significant development, Massachusetts Attorney General Maura Healey has filed a lawsuit against Publicis Health, one of Purdue Pharma's marketing partners, in Suffolk Superior Court. The lawsuit alleges that Publicis Health engaged in deceptive marketing practices related to the promotion of OxyContin.

The lawsuit, filed on behalf of the Commonwealth of Massachusetts, accuses Publicis Health of contributing to the opioid epidemic through its marketing efforts. However, Publicis Health has strongly denied the allegations, with their spokesperson calling the lawsuit "completely without basis."

Publicis Health, in their response, stated that they support organisations fighting the opioid epidemic in Massachusetts and across the country. They also emphasised that all their work related to the opioid epidemic was completely lawful. The company further clarified that they acted solely as an advertising agency in their work related to the opioid epidemic.

It is important to note that the other marketing partners of Purdue Pharma implicated in deceptive marketing practices related to OxyContin are not specifically named in the available sources. Purdue Pharma itself and the Sackler family are primarily noted for their role and legal actions.

The lawsuit comes in connection with Purdue Pharma's reckoning over its promotion of OxyContin. Publicis Health's role in these practices is under intense scrutiny, and the outcome of this lawsuit could have significant implications for the company and the pharmaceutical industry as a whole.

As the case progresses, more details are expected to emerge, shedding light on the extent of Publicis Health's involvement in the promotion of OxyContin and its impact on the opioid epidemic. The public will be closely watching this case as it unfolds.

Read also: